These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 4905448)
1. Advances in medicine. Tudhope GR Practitioner; 1969 Oct; 203(216):405-17. PubMed ID: 4905448 [No Abstract] [Full Text] [Related]
2. [Immunosuppressive cytostatic preparations in the therapy of certain diseases]. Petrov NS; Dygin VP; Viazitskiĭ PO; Tokarev NF Voen Med Zh; 1975 Sep; (9):43-7. PubMed ID: 1181721 [No Abstract] [Full Text] [Related]
3. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis. Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190 [No Abstract] [Full Text] [Related]
4. High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions. McSweeney PA; Furst DE; West SG Arthritis Rheum; 1999 Nov; 42(11):2269-74. PubMed ID: 10555019 [No Abstract] [Full Text] [Related]
5. Cyclosporine and methotrexate for severe rheumatoid arthritis. Storb R; Thomas ED N Engl J Med; 1995 Dec; 333(23):1568; author reply 1568-9. PubMed ID: 7477182 [No Abstract] [Full Text] [Related]
6. [Immunosuppressive therapy in internal medicine]. Scheiffarth F Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):157-62. PubMed ID: 4149205 [No Abstract] [Full Text] [Related]
7. [Immunosuppressive therapy in autoimmune diseases]. Schwarz-Eywill M Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):93-100. PubMed ID: 10355057 [TBL] [Abstract][Full Text] [Related]
8. [Preliminary studies on immunosuppressive therapy of connective tissue disorders]. Gillardi U; Liso V; Troccoli G Haematologica; 1970 Dec; 55(12):759-65. PubMed ID: 5003115 [No Abstract] [Full Text] [Related]
9. [Immunodepressive methods used in clinical medicine]. Frei PC Rev Med Suisse Romande; 1974 Sep; 94(9):711-21. PubMed ID: 4548210 [No Abstract] [Full Text] [Related]
10. Immunosuppressive therapy in management of non-malignant disease. Fennelly JJ; Fitzgerald MX; Fitzgerald O J Ir Med Assoc; 1970 Apr; 63(394):141-6. PubMed ID: 5418154 [No Abstract] [Full Text] [Related]
11. [Immunosuppressive therapy - review of up-to-date experience in the world and in our country]. Jovanović D Med Arh; 1976; 30(5):307-15. PubMed ID: 1018520 [No Abstract] [Full Text] [Related]
12. [Treatment with tacrolimus in autoimmune diseases]. Sádaba B; Azanza JR; García Quetglas E; Fernández V Rev Med Univ Navarra; 2004; 48(3):24-38. PubMed ID: 15622922 [TBL] [Abstract][Full Text] [Related]
13. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases]. Szegedi G Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537 [TBL] [Abstract][Full Text] [Related]
14. [D-penicillamine in the treatment of rheumatoid arthritis]. Krikulov VP; Anderson AA; Iudina TI; Shibalkin VD Vopr Revm; 1980; (4):58-62. PubMed ID: 7245686 [No Abstract] [Full Text] [Related]
15. [32 cases of nephrosis in children. Improvement of the prognosis by immunosuppressive drugs]. Mongeau JG; Robillard J Union Med Can; 1968 Nov; 97(11):1578-85. PubMed ID: 5746556 [No Abstract] [Full Text] [Related]